Last update May 1, 2016
Very Low Risk
It is excreted into breast milk in clinically non-significant amount, in fact a much lower amount than the dose used for the treatment or prophylaxis of infection in neonates and infants. Even more, no problems that would be attributable to rifampicin have been observed among infants whose mothers were taking this medication.
It can cause an orange discoloration of body fluids, including the mother’s milk.
Take into account possible negative results in bacterial cultures of febrile infants, when their mothers are on antibiotics.
American Academy of Pediatrics states that it is usually compatible with breastfeeding medication.
WHO List of Essential Medicines 2002: compatible with breastfeeding.
We do not have alternatives for Rifampicine since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM